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ABSTRACT 25 
 26 
Gilthead sea bream juveniles were fed different doses (0, 50, 100, 200, 300 ppm) of NEXT 27 
ENHANCE ®150 (NE) for 9 weeks. Feed gain ratio (FGR) was improved by a 10% with 28 
all the doses, but feed intake decreased in a dose dependent manner. The optimum inclusion 29 
level to achieve maximum growth was set at 100 ppm. The hepatosomatic index did not 30 
vary and only at the highest dose, viscerosomatic and splenosomatic indexes were 31 
significantly decreased. No significant changes were found in haematological parameters, 32 
plasma biochemistry, total antioxidant capacity and respiratory burst. In a second trial, NE 33 
was given at 100 ppm alone (D1) or in combination with the prebiotic PREVIDA® (0.5%) 34 
(PRE) (D2) for 17 weeks. There were no differences in the growth rates, and FGR was 35 
equally improved for D1 and D2. No significant changes in haematology and plasma 36 
antioxidant capacity were detected. The histological examination of the liver and the 37 
intestine showed no outstanding differences in the liver, but the number of mucosal 38 
foldings appeared to be higher in D1 and D2 vs CTRL diet and the density of enterocytes 39 
and goblet cells also appeared higher, particularly in the anterior intestine. A 87-gene PCR-40 
array was constructed based on our transcriptomic database (www.nutrigroup-41 
iats.org/seabreamdb) and applied to samples of anterior (AI) and posterior (PI) intestine. It 42 
included 54 new gene sequences and other sequences as markers of cell differentiation and 43 
proliferation, intestinal architecture and permeability, enterocyte mass and epithelial 44 
damage, interleukins and cytokines, pattern recognition receptors (PRR), and mitochondrial 45 
function and biogenesis. More than half of the studied genes had significantly different 46 
expression between AI and PI segments. The functional significance of this differential 47 
tissue expression is discussed. The experimental diets induced significant changes in the 48 
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expression of 26 genes. The intensity of these changes and the number of genes that were 49 
significantly regulated were higher at PI than at AI. At PI, both diets invoked a clear down-50 
regulation of genes involved in cell differentiation and proliferation, some involved in cell 51 
to cell communication, cytokines and several PRR. By contrast, up-regulation was mostly 52 
found for genes related to enterocyte mass, cell epithelial damage and mitochondrial 53 
activity at AI. The changes were of the same order for D1 and D2, except for fatty acid-54 
binding proteins 2 and 6 and the PRR fucolectin, which were higher in D2 and D1 fed fish, 55 
respectively. Thus, NE alone or in combination with PRE seems to induce an anti-56 
inflammatory and anti-proliferative transcriptomic profile with probable improvement in 57 
the absorptive capacity of the intestine that would explain the improved FGR. 58 
 59 
Key words: Teleostei, prebiotics, carvacrol, thymol, aquafeeds, intestine, transcriptomics, 60 
immunology    61 
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1. Introduction  62 
 63 
The role of dietary nutrients and additives on immune system function in fish has 64 
been investigated for several decades as a means of reducing the presence of opportunistic 65 
pathogens and simultaneously stimulating the host immunological responses [1, 2]. Among 66 
the different nutraceutical products, prebiotics, probiotics and antioxidants are most 67 
studied. Prebiotics are non-digestible selectively fermented feed ingredients that allow 68 
specific changes in the composition and/or activity in the gut microbiota that confers 69 
benefits upon host wealth and health, which mediate immunological development and 70 
functionality, particularly at the mucosal interface within the gastrointestinal (GI) tract [3-71 
5]. The use of dietary prebiotics in farmed fish has been approached, sometimes with 72 
contradictory effects [6-10]. 73 
Phytoadditives obtained from different herbs have also been tested in fish feeds for 74 
effects on fish immune response and disease susceptibility [11-15]. They represent a 75 
promising alternative to traditional drugs as they have low costs and some of them are 76 
legally registered as food additives for human consumption [16]. Phytogenic extracts 77 
containing phenolic and flavonoid chemical compounds are known to exert an array of 78 
positive effects that include improvement of gut microbiota composition, enhanced immune 79 
function and resistance to pathogens, and improved gut barrier structure and function in 80 
humans and animals [17, 18]. Among these additives, carvacrol and thymol are essential 81 
oils from oregano (Origanum vulgare) that have been shown to improve growth 82 
performance in different animal production systems [19, 20]. They are also known for their 83 
antibacterial [21] and antioxidant [22] properties, for synergizing effects of antibiotics [23], 84 
and for their potential applications in foods [24], including fish fillets [25, 26]. Carvacrol in 85 
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particular exhibits a range of biological activities: antimicrobial, antitumoral, 86 
antimutagenic, antigenotoxic, analgesic, antispasmodic, antiinflammatory, angiogenic, 87 
antiparasitic, antiplatelet, AChe inhibitory, antielastase, insecticidal, antihepatotoxic and 88 
hepatoprotective (reviewed by Baser [27]). However, its role as an immunostimulant is 89 
rather controversial, with contradictory results in swine [28-30]. Carvacrol administration 90 
in fish species is starting to be documented. Thus far, it has been tested alone in tilapia [31] 91 
and European sea bass [32], or in combination with thymol in channel catfish [33] and 92 
rainbow trout [34, 35]. In these previous experiments, these phytoadditives had a beneficial 93 
effect on growth and disease resistance to bacterial challenges. However, the pathways 94 
involved in their immunostimulant and/or antioxidant roles in fish are still poorly 95 
understand.  96 
Thus, in the present study we tested the effect of Next Enhance NE®150 (NE), an 97 
encapsulated combination of carvacrol and thymol, as a feed additive for gilthead sea 98 
bream, alone or in combination with the prebiotic Previda® (PRE). In a first short-term 99 
trial, the best dose of NE was established in terms of growth performance. Subsequently, a 100 
longer trial was set up to assess the effect on gut and liver histomorphology, antioxidant 101 
status, and the expression of immune and intestinal integrity related genes,  using an 87-102 
gene PCR-array derived from the updated transcriptomic database of gilthead sea bream 103 
[36] hosted at www.nutrigroup-iats.org/seabreamdb. The development of the array involved 104 
the molecular definition of 54 new gilthead sea bream sequences, selected together with 105 
other known sequences as markers of intestine function, immunity and integrity, based on 106 
the intestine gene expression profiling in fish challenged with different diets and the 107 
parasite Enteromyxum leei [37-40].  108 
 109 
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2. Materials and Methods 110 
 111 
2.1. Animal care, feeding trials design and sampling procedure 112 
Clinically healthy juvenile gilthead sea bream (GSB) were obtained from a local 113 
commercial hatchery and acclimatized to the IATS rearing facilities for four weeks. A first 114 
feeding trial (trial 1) was set up to establish the best NE dose. Fish with an initial weight of 115 
26-27 g (1st May) were randomly distributed in triplicated 90L tanks (20 animals/tank) and 116 
fed a basal diet (CTRL, see below) or the experimental diets with four inclusion levels of 117 
the active compound NE: 50 ppm (D50), 100 ppm (D100), 200 ppm (D200) and 300 ppm 118 
(D300). Fish were fed twice a day by visual satiety during 9 weeks and were sampled at the 119 
end of the experiment for total biomass biometry. At this time, 24 fish per diet were 120 
sacrificed to obtain organosomatic indexes, blood, plasma and tissues samples.  121 
In a second feeding trial (trial 2), the best NE dose established in trial 1 (D100) was 122 
used alone (D1) or in combination with the prebiotic PRE at 0.5 % (D2), using the same 123 
basal diet (CTRL). Fish were distributed in June in three replicated 500L tanks for each diet 124 
with an initial number of 40 fish per tank. Fish were fed ad libitum by hand twice a day. 125 
Daily feed intake was recorded. A biometric sampling was performed on all fish after 17 126 
weeks of feeding. A subsample of 30 fish per diet (10 per tank) was randomly sacrificed to 127 
obtain blood, plasma and tissue for gene expression and histology.  128 
In both trials, day length followed natural changes at IATS latitude (40º5’ N, 129 
0º10’E). Natural sea water (37.5‰ salinity) was 5 µm-filtered and UV irradiated for supply 130 
to the fish in a flow through system. Flow rate and oxygen content were checked daily and 131 
kept uniform in all tanks.  Water temperature ranged from 19 to 25 ºC. In lethal samplings, 132 
blood was quickly drawn from caudal vessels with heparinized syringes, one blood aliquot 133 
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was immediately used to measure the respiratory burst activity, another aliquot was used to 134 
measure haemoglobin and the remaining blood was centrifuged at 3000 g for 20 min at 4 135 
◦C, and plasma aliquots were stored at −80 ◦C until used in anti-oxidant and metabolite 136 
analyses. Fish were killed by an overdose of the anaesthetic aminobenzoic acid ethyl ester 137 
(MS-222; Sigma, Saint Louis, MO, USA) prior to organ weight and tissue collection for 138 
histology and gene expression analysis. Anterior and posterior intestine portions were 139 
rapidly excised, frozen in liquid nitrogen and stored at -80ºC until RNA isolation.  140 
All procedures were carried out in accordance with the principles published in the 141 
European animal directive (86/609/EEC) for the protection of experimental animals, and 142 
was approved by the Consejo Superior de Investigaciones Científicas (CSIC) ethics 143 
committee and IATS Review Board. 144 
 145 
2.2. Diet composition and preparation 146 
The concentration of NE in the different diets was calculated according to the 147 
amount of the active compound and both NE and PRE were incorporated into the basal diet 148 
before extrusion by SPAROS Lda (Faro, Portugal). The composition of the basal diet 149 
(CTRL) can be found in Table 1. NE has a 50% of the active compound and to obtain the 150 
target doses it was added to the basal diet from 100 to 600 mg/kg. The active ingredients in 151 
NE include thymol and carvacrol at a 1:1 ratio. PRE consists of broad range of 152 
oligosaccharides, from all-natural hemicellulose extract. Mannose represents more than 153 
51% and xylose, glucose and galactose are the other main oligosaccharide components. 154 
Small quantities of arabinose, rhamnose and fucose are the remaining constituents. The 155 
broad degree of polymerization distribution in the oligosaccharides contributes to the broad 156 
spectrum prebiotic activity found in the gut [6, 41]. 157 
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 158 
2.3. Biometrical data 159 
Body weight, whole viscera, liver and spleen weights were measured and the 160 
viscerosomatic (VSI), the hepatosomatic (HSI) and splenosomatic (SSI) indexes were 161 
calculated as the ratio between the organ weight and body weight. Specific growth rates 162 
(SGR) were calculated as follows: SGR (%) = 100 × (lnWt – lnW0)/t, where W0 represents 163 
weight at the beginning of the period, Wt the weight at the end of the trial and t the number 164 
of growth days. Feed gain ratio (FGR) was calculated as the ratio between feed intake and 165 
weight gain. 166 
 167 
2.4. Blood haematology and biochemistry 168 
Haemoglobin concentration (Hb) was determined with a HemoCue B-Haemoglobin 169 
Analyser® (AB, Leo Diagnostic, Sweden), which uses a modified azide methaemoglobin 170 
reaction for haemoglobin quantification. Blood was drawn into disposable microcuvettes 171 
which contain reagents in dried form that produce the red blood cell lysis and the 172 
conversion of haemoglobin to methaemoglobin by sodium nitrate, which is then combined 173 
with azide. The absorbance of the azide methaemoglobin is then photometrically measured 174 
at 565 nm and 880 nm.  175 
Plasma glucose was measured by the glucose oxidase method (ThermoFisher 176 
Scientific, Waltham, Massachusetts, USA). Total plasma cholesterol was determined using 177 
cholesterol esterase/cholesterol dehydrogenase reagent (ThermoFisher Scientific). Plasma 178 
triglycerides (TG) were determined using lipase/glycerol kinase/glycerol-3phosphate 179 
oxidase reagent (ThermoFisher Scientific). Total plasma proteins were measured with the 180 
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Bio-Rad protein reagent (Hercules, California, USA) with bovine serum albumin as 181 
standard. 182 
The total antioxidant capacity (TAC) was measured in serum samples with a 183 
commercial kit (Cayman Chemical), as previously described [42]. Induction of the 184 
respiratory burst (RB) activity in blood leucocytes was measured directly from heparinised 185 
blood [42]. Briefly, blood was incubated with a luminol suspension containing PMA for 1 h 186 
and the resulting integral chemiluminescence in relative light units (RLU) was calculated. 187 
 188 
2.5. Histology 189 
For histological examination, pieces of liver, anterior and posterior intestine were 190 
fixed in 10% buffered formalin, embedded in Technovit resin (Kulzer, Germany), 1.5 µm-191 
sectioned and stained with haematoxylin and eosin (H&E) and toluidine blue. 192 
 193 
2.6. Gene sequence analysis 194 
 The nutrigroup-iats.org/seabreamdb database contains more than 60,000 assembled 195 
contigs with 17,797 non-redundant sequences and more than 14,500 Swissprot descriptions. 196 
This set of sequences is specially enriched on intestinal reads and this allowed the 197 
unequivocal identification (E-value > 3e-42) of 54 new intestinal-related genes, uploaded to 198 
GenBank with accession numbers KF857309-KF857334/KF857336-KF857346/KF861987-199 
KF862004 (Table 2). The list included 14 markers of cell differentiation and proliferation 200 
(BMPR1A, IHH, GLI1, GLIS3, HHIP, WLs, Myc, CTNNB1, Tcf4, NLE1, HES1-B, GFI-201 
1, KLF4, VIM),  3 markers of cell adhesion (ITGB1BP1, ITGB6, ILK), 8 markers of tight-202 
junctions (OCLN, CLDN12, CLDN15, TJP1, CDH1, CDH17, F11R, CXADR), 1 marker 203 
of desmosomes (DSP), 3 markers of gap junctions (CX32.2, CX32.7, GJB4),  4 markers of 204 
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differentiated enterocytes (ALPI, FABP1, PABP2, FABP6), 2 markers of oxidative stress 205 
(CALR, CANX), 7 chemokine receptors (CXC, CCL25, CCR3, CCR9, CR11, CCL20, 206 
CD48, CD276) and 12 pattern recognition receptors (PRRs) (TLR1, TLR2, TLR5, NOD1, 207 
MRC1, CD209, CD302, CLEC10A, LGALS1, LGALS8, CSL2, FCL).  Thirty three among 208 
them comprised complete codifying sequences with open reading frames of  332-2708 209 
nucleotides in length and a variable number of reads (2-4026) composing the assembled 210 
sequences.    211 
 212 
2.7. Gene expression analysis 213 
Total RNA of 6 fish from each dietary treatment of trial 2 was extracted from 214 
anterior and posterior intestine samples with the MagMAX TM-96 total RNA isolation kit 215 
(Life Technologies). The RNA yield was 50-100 µg with absorbance measures (A260/280) 216 
of 1.9–2.1 and RIN (RNA integrity number) values of 8-10 with the Agilent 2100 217 
Bioanalyzer, which is indicative of clean and intact RNA. Reverse transcription (RT) of 218 
500 ng total RNA was performed with random decamers, using the High-Capacity cDNA 219 
Archive Kit (Applied Biosystems) following manufacturer’s instructions. Negative control 220 
reactions were run without reverse transcriptase and real-time quantitative PCR was carried 221 
out with a CFX96 Connect™ Real-Time PCR Detection System (Bio-Rad, Hercules, CA, 222 
USA), using a 96-well PCR array layout designed for simultaneously profiling a panel of 223 
87 genes under uniform cycling conditions (Table 3). The GenBank accession numbers for 224 
all the genes included in the assay and the PCR-array layout are shown in Supplementary 225 
Table 1. This set of genes included markers of cell differentiation and proliferation (14), 226 
intestinal architecture and permeability (19), enterocyte function and epithelia damage (9), 227 
immune-surveillance (interleukins, cytokines and chemokines receptors, 21; PRRs, 13) and 228 
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mitochondria function and biogenesis (11). Housekeeping genes and controls of general 229 
PCR performance are included on each array, and all the liquid manipulations required to 230 
perform the PCR array were made by means of the EpMotion 5070 Liquid Handling Robot 231 
(Eppendorf, Hamburg, Germany). Briefly, for each RT reaction, 660 pg of total input RNA 232 
was diluted to a 25 ml volume for each PCR reaction. PCR-wells contained a 2x SYBR 233 
Green Master Mix (Bio-Rad, Hercules, CA, USA), and specific primers at a final 234 
concentration of 0.9 µM were used to obtain amplicons of 50–150 bp in length 235 
(Supplementary Table 2).  236 
The program used for PCR amplification included an initial denaturation step at 237 
95ºC for 3 min, followed by 40 cycles of denaturation for 15 s at 95ºC and 238 
annealing/extension for 60 s at 60ºC. The efficiency of PCR reactions was always higher 239 
than 90% (amplification factor > 1.90 and similar for all genes), and negative controls 240 
without sample templates were routinely used for each primer set. The specificity of 241 
reactions was verified by analysis of melting curves (ramping rates of 0.5ºC/10 s over a 242 
temperature range of 55–95ºC), linearity of serial dilutions of RT reactions, and 243 
electrophoresis and sequencing of PCR amplified products. Fluorescence data acquired 244 
during the PCR extension phase were normalised using the delta-delta Ct method [43]. β-245 
actin, elongation factor 1, α-tubulin and 18S rRNA were initially tested for gene expression 246 
stability using GeNorm software, and the most stable gene was found to be β-actin (M 247 
score = 0.17); therefore, this gene was used as a housekeeping gene in the normalisation 248 
procedure for routine assays. Technical replicates of the samples were run initially to test 249 
the reproducibility of the method, but the obtained data had a very high reproducibility 250 
score and technical replicates were finally omitted. For multi-gene analysis comparisons, 251 
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all data values were referenced to the expression level of IL-1β at the anterior intestine of 252 
CTRL fish with an arbitrarily assigned value of 1. 253 
 254 
2.8. Statistical analysis 255 
Data on fish performance, biochemistry and gene expression were analyzed using 256 
one-way analysis of variance (ANOVA-I), followed by a Student-Newman-Keuls post hoc 257 
test. When the test of normality or equal variance failed, a Mann-Whitney Rank Sum test or 258 
a Kruskal-Wallis ANOVA on ranks followed by Dunn’s method was applied instead, 259 
respectively. The significance level was set at P < 0.05. All analyses were conducted using 260 
SPSS package version 19.0 (SPSS Inc., Chicago, IL, USA). 261 
 262 
3. Results 263 
 264 
3.1. Trial 1: dose-effect of NE 265 
Table 4 shows the dose-dependent effects of NE on the growth performance and 266 
organosomatic indexes. Feed intake was significantly and progressively reduced in fish fed 267 
with the four levels of NE. There was also a progressive, but not statistically significant 268 
decrease in the final body weight, which did not negatively affect specific growth rate 269 
(SGR). Consequently, feed gain ratio (FGR) was progressively improved with increasing 270 
inclusion of NE. The weight of whole viscera and liver, as well as the viscerosomatic (VSI) 271 
and splenic (SI) indexes were significantly decreased only in D300 fish. 272 
No statistically significant changes were detected in Hb and plasma biochemistry, 273 
TAC and respiratory burst for any of the experimental diets (Table 4). Nevertheless, a 274 
decreasing trend in plasmatic cholesterol and glucose levels and an increasing trend in the 275 
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respiratory burst (RB) of circulating leucocytes were observed with increasing doses of 276 
NE®150. In fact, the mean RB of D300 fish almost doubled that of CTRL fish, but 277 
differences were not significant due to the high individual variability. 278 
 279 
3.2. Trial 2: long term effects of NE 280 
Growth performance. Table 5 shows the growth performance of fish after 17 weeks 281 
of experimental feeding. There were no differences in the final body weight or in the SGR 282 
between the three diets, but feed intake was significantly lower in D2 than CTRL fish, and 283 
FGR was significantly better for D1 and D2 than for CTRL. There were no significant 284 
changes in Hb, though a certain decrease was found in both experimental diets, and a slight 285 
increase in plasma TAC was also found. 286 
Histological observations. The histological examination of the liver and the two 287 
segments of the intestine of CTRL and D1 and D2 fed fish showed no outstanding 288 
differences in the liver, with a high level of fat in hepatocytes in general (Fig. 1A-B). Initial 289 
steatosis was observed only in one D2 fish and one D1 fish. The number of mucosal 290 
foldings appeared to be higher in D1 and D2 vs CTRL diet and the density of enterocytes 291 
and goblet cells also appeared higher, particularly at the anterior segment (Fig. 1C-F). 292 
Transcriptomic profile. The relative expression of the 87 studied genes at the 293 
anterior (AI) and posterior (PI) intestine are shown in supplementary Table 3. To simplify 294 
the interpretation of the results, only the fold changes of the significantly different genes 295 
are represented in Figs. 2 and 3. The comparison of the constitutive expression at PI vs AI 296 
in CTRL fish revealed that 52.8 % (46) of the studied genes were significantly different (P 297 
< 0.05) (Fig. 2). In particular, genes related to cell differentiation and proliferation, 298 
intestinal architecture and permeability, cytokines and PRRs were more expressed at PI, 299 
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whereas those related to enterocyte mass and epithelial damage and mitochondrial function 300 
and biogenesis were more expressed at AI. It was especially remarkable the higher 301 
expression of I-MUC at PI and IHH at AI. FABP6 transcripts were only consistently 302 
detected at PI, whereas FABP2 only at AI. 303 
Fig. 3 shows the 26 differentially expressed genes for each diet and intestinal 304 
segment. The trend of the changes (red for up-regulation, green for down-regulation) 305 
induced by experimental diets was mainly down-regulation and the intensity of the changes 306 
and the number of significantly regulated genes were higher at PI than AI. In general, the 307 
magnitude of the changes was similar for D1 and D2 fish, and for some genes (TLR5 and 308 
TLR9) the magnitude was even higher than constitutional differences between the two 309 
intestinal segments in CTRL fish. Among the 14 studied genes related to cell differentiation 310 
and proliferation, a pattern of down-regulation was observed for six genes only at PI, and 311 
particularly more in D1 fish. Bone morphogenetic protein receptor type IA (BMPR1A) was 312 
the only gene that showed exclusive down-regulation in D2 fish. Vimentin (VIM) was 313 
down-regulated both in D1 and D2 fish at PI. The transcriptomic profile of the 19 studied 314 
genes involved in intestinal architecture and permeability (cell adhesion, tight junction, 315 
desmosome and gap junction proteins and mucins) was also decreased for four genes only 316 
at PI and very similarly with both experimental diets. 317 
More than a fourth (26.5%) of the 34 measured genes related to immunosurveillance 318 
was also significantly down-regulated. The dis-regulation affected cytokines, including 319 
interleukins (IL), and PRRs. IL-6 was the only gene decreased in both intestinal segments 320 
by both diets, whereas TNF-α was the only gene decreased exclusively by D2. The only 321 
significantly up-regulated PRR, which was also the gene with the highest fold change, was 322 
fucolectin (FCL), but only by D1 at both intestinal segments. By contrast, up-regulation 323 
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was mostly found for genes related to enterocyte mass, cell epithelial damage and 324 
mitochondrial activity (4 out of 20 measured genes), and none of them was differentially 325 
expressed at both intestinal segments. Interestingly, the gene expression of fatty acid-326 
binding proteins 2 and 6 (FABP2, FABP6) was significantly increased at AI and PI by D2, 327 
respectively. The only down-regulated genes in this gene category were CANX and ALPI, 328 
both by D2 at PI and AI, respectively. 329 
 330 
4. Discussion 331 
 332 
This is the first integrated study of the effects of combining essential oils and a 333 
prebiotic in the diet of a Mediterranean farmed fish. The threshold dose of NE was clearly 334 
established at 100 ppm in the first trial, as higher doses slowed growth due to a reduced 335 
feed intake, and possibly a lower lymphohaematopoietic function (low SI). When using the 336 
100 ppm dose alone (D1) or combined with PRE (D2) in the second trial, the decrease in 337 
feed intake was confirmed and FGR was equally improved. Previously, carvacrol has been 338 
shown to be a growth enhancer in poultry and pig studies [27] and feed conversion was also 339 
improved with carvacrol or thymol in some fish trials with tilapia [31], channel catfish [33] 340 
and rainbow trout [35].  However, no improvement was obtained when using a combination 341 
of carvacrol and thymol in rainbow trout [33] or carvacrol alone in European sea bass [32] 342 
for 8 or 9 weeks, respectively. The use of some prebiotics also improved feed conversion in 343 
several fish species [6, 44-47], but we did not find significant differences between not 344 
adding (D1) or adding (D2) the prebiotic with the assayed dose. In the current study, 345 
organosomatic indexes (HSI, VSI and SI) were only altered with the highest dose (D300). 346 
Similarly, HSI and VSI were not altered in channel catfish fed thymol and/or carvacrol 347 
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[33], in European sea bass fed with carvacrol [32] or in starry flounder fed a dairy-yeast 348 
prebiotic [45]. By contrast, these indexes were decreased when Orego-Stim® (OS) 349 
(contains natural oregano oil) was added [33]. 350 
No significant changes in plasma metabolites, Hb, respiratory burst and TAC were 351 
detected in the feeding trials, though a slight increase in TAC was detected with D100 and 352 
D2. Similarly, in channel catfish fed carvacrol + thymol no significant changes were found 353 
in catalase and superoxide dismutase activity. These activities were only increased with OS 354 
diet [33]. By contrast, serum catalase was significantly increased in rainbow trout fed either 355 
carvacrol or thymol [35] and key enzymes of antioxidant defences were increased in white 356 
sea bream fed high levels of non-starch polysaccharides [48]. 357 
In the current work, the transcriptomic study focused on the gut because the 358 
intestine not only digests food and absorbs nutrients, but also provides a defence barrier 359 
against pathogens and noxious agents ingested [49]. The transcriptomic profile was based 360 
on the molecular definition of 87 (including 54 new) gilthead sea bream sequences, selected 361 
as markers of intestine function, integrity and immunity. For some of these genes, limited 362 
previous information has been published for salmonids and model fish species, while others 363 
have no data available on their functional regulation in fish. Thus, the new data published 364 
here will open the door to new studies focused on gut immunity and function. This 365 
approach is aligned with current strategies in human health to study nutritional aspects of 366 
metabolic inflammation, in which transcriptomic biomarkers have been shown to have a 367 
potential in profiling pro- and anti-inflammatory mechanisms [50]. 368 
First of all, it is interesting to note the differential constitutive profile of more than 369 
half of the studied genes between the two intestinal segments. Structurally, it is known that 370 
the AI of fish is primarily involved in the absorption of lipids and proteins, while the PI can 371 
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take up macromolecular proteins. The PI also appears to be the primary site where antigen 372 
uptake occurs and an immune response is initiated [51]. This is in accordance with the 373 
observed higher expression of some cytokines and many pattern recognition receptors 374 
(PRR), including TLRs, NODs and lectins at the PI than at the AI of GSB. PRRs are 375 
expressed by innate immune cells and activated by specific pathogen-associated molecular 376 
patterns (PAMPs) present in microbial molecules or by damage-associated molecular 377 
patterns (DAMPs) exposed on the surface of, or released by, damaged cells. Binding of 378 
PAMPs or DAMPs to PRRs promotes the synthesis of cytokines and the subsequent 379 
triggering of the innate and specific immune response. Information on fish TLRs has 380 
increased considerably in the last years [52, 53] and TLRs in fish are known to be 381 
expressed especially in immune-related organs (spleen, head-kidney) and mucosal–382 
epithelial barriers (gills, gut, skin), but there is no information on its differential expression 383 
along the GI tract in fish.   384 
Another group of genes more represented at the PI of GSB included several cell to 385 
cell communication genes, such as some claudins, occludin and other tight junction (TJ) 386 
and gap junctions (GJ) proteins and mucins. TJs are the most apical component of the 387 
junctional complex, providing one form of cell-cell adhesion in enterocytes and playing a 388 
critical role in regulating paracellular barrier permeability. Claudins are the major structural 389 
and functional components of TJs that largely determine TJ permeability, with at least 24 390 
members in mammals [54]. In fish, about 63 genes encoding for claudins have been 391 
reported in 16 teleost species [55]. The structure and function of the TJ complex in teleosts 392 
appears to be fundamentally similar to those of other vertebrate groups [56], though some 393 
claudins have no orthologous in mammals. Even though at least 30 claudins have been 394 
reported in the GI tract of teleosts, only a small fraction of them have been examined to 395 
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date and almost no functional studies have been conducted [57]. The GI tract of teleosts has 396 
been reported to progressively “tighten,” from the anterior to posterior part, thus preventing 397 
leakage of water back into the gut lumen [58], this would agree with the observed higher 398 
expression of genes related to TJ complexes at the PI, especially those that are considered 399 
as tightening, such as TJP1, occludin and CXADR, and would mean a decreased 400 
paracellular permeability. Claudins 12 and 15 have previously been found in the intestine of 401 
fish, however their functions throughout the animals groups are unclear, as they vary 402 
depending on the system studied. Claudin 15 is considered in humans a pore-forming type, 403 
but it has been found to increase in Atlantic salmon intestine in response to seawater 404 
acclimation [59] and claudin 12 expression decreases from unfertilized oocytes to 405 
segmented embryo in Atlantic cod [57]. The different mucin  types  have a tissue-specific 406 
distribution in the GI of GSB, and the current results confirmed the higher expression of 407 
intestinal mucin (I-MUC) at the PI [40]. 408 
Direct communication between adjacent cells mainly occurs through GJ, which are 409 
intercellular channels formed by members of the connexin family. GJ allow the direct cell-410 
to-cell passage of electrical signals, ions, and small molecules up to approximately 1,000 411 
daltons in mass [59] and are also master regulators of cell growth and cell death [60]. 412 
Numerous factors are known to drive physiological GJ production and activity and 413 
connexin gene transcription is ruled by specific sets of transcription factors in mammals 414 
[61]. The connexin family comprises at least twenty isoforms in mammals, and there seems 415 
to be a higher number in fish, and some of them, such as CX32.2 and CX32.7 are fish-416 
specific [62]. This is the first report on the expression of these two connexins in fish 417 
intestine, and the first report of GJB4 (also named connexin 30.3) regulation in fish. The 418 
previous scarce information on CX32.2 and CX32.7 in fish is mainly related to their 419 
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presence and regulation in gonads and gamets [58, 63, 64], and GJB4 in mammals is 420 
mainly found in skin and kidney and its mutations provoke skin diseases in humans [65]. 421 
Therefore we can only speculate about their differential expression in the two intestinal 422 
segments of GSB. What we know about gastrointestinal GJ is that they play a specific role 423 
in pacemaking and neurotransmission and thus the regulation of motility in mammals, and 424 
some enteric bacteria use these channels for cell invasion [66]. 425 
The differential function of both intestinal segments also explains the differential 426 
expression of enterocyte mass and epithelial damage related genes, such as FABPs. 427 
Although numerous experiments have provided evidence for several biological functions of 428 
FABPs, the precise role of FABPs in cell physiology remains unresolved. These studies 429 
suggest several functions: (1) the uptake and transportation of fatty acids and other 430 
hydrophobic ligands; (2) cell growth and differentiation; (3) regulation of specific genes; 431 
(4) sequestering of fatty acids to protect the cell from the detergent effects of excess fatty 432 
acids; and (5) targeting of fatty acids to various transport and signalling pathways. FABP2 433 
transcripts were mainly found at AI, in agreement with the previous studies that showed a 434 
proximal to distal decrease in the intestine of several fish species [67-69], which is related 435 
to the major absorption of nutrients at the anterior segment. By contrast, FABP6 transcripts 436 
were detected exclusively at PI, the tissue homologous to the mammalian ileum, as well as 437 
in the distal region of zebrafish intestine [70], which suggests that FABP6 may have the 438 
same role in the uptake of bile salts, which are absorbed in the ileal epithelium of mammals 439 
[71].  440 
Concerning the effects of the experimental diets on the gut transcriptomic profile, 441 
the results showed that several cell to cell communication genes, such as some claudins and 442 
other TJ proteins, were down-regulated, particularly at PI. Alteration of TJs in higher 443 
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vertebrates leads to a number of pathophysiological diseases causing malabsorption of 444 
nutrients and intestinal structure disruption, which may even contribute to systemic organ 445 
failure. Among the eight genes related to TJ proteins (ocludins, claudins, cadherins, etc.) 446 
described for the first time in GSB in the current study, three of them were affected by the 447 
experimental diets besides the gap junction protein GJB4. There is no information of the 448 
effect of diets or nutrients in fish TJs, though in mammals, several studies have shown that 449 
intestinal bacteria and various dietary components can regulate epithelial permeability by 450 
modifying expression and localization of TJ proteins [72]. The effects of the detected 451 
down-regulation on the intestinal permeability of GSB are unknown, but in any case it did 452 
not affect any of the measured plasma metabolites. Most probably, it would contribute to a 453 
higher permeability and therefore to an enhanced intestinal absorption, and would explain 454 
the observed higher FGR. This would  be in line with the effects of chitosan, a 455 
polysaccharide widely used in the food industry, known for its absorption-enhancing 456 
properties due to the demonstrated increased paracellular permeability, by altering the 457 
distribution of TJP1 [73]. Considering the importance and complexity of the teleostean GI 458 
tract, the role of all these proteins in this tissue will be an exciting area for future study. 459 
Most of the differentially expressed genes related to cell differentiation and 460 
proliferation were down-regulated at PI, in D1 fish, with vimentin (VIM) being the only 461 
one affected by both diets. VIM is one of the large intermediate filaments of eukaryotic 462 
cells’ cytoskeleton. It is the major protein in mesenchymal cells and is frequently used as a 463 
developmental marker of epithelial to mesenchymal transitions that take place during 464 
embryogenesis and metastasis [74], yet the functional implications of the expression of this 465 
protein are poorly understood in mammals [75] and almost unknown in fish. In salmon, 466 
VIM-like transcripts were co-localized with the presence of intermediate filaments in 467 
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chordocytes, indicating that the transcript is translated and directly used in the cytoskeleton 468 
[76]. It is also considered a mesenchymal marker in GSB hepatocytes [77] and VIM+ cells 469 
were demonstrated by immunocytochemistry in the gill filament epithelium of 470 
Oreochromis niloticus [78]. In the current study, VIM was down regulated in all the 471 
experimental diet groups and intestinal segments, though the statistical differences were 472 
only found at PI. As VIM is considered a marker of undifferentiated cells, this down 473 
regulation could indicate a higher degree of cell maturation in experimentally fed fish. 474 
Interestingly, VIM has also been described as an endogenous, activating ligand for Dectin-1 475 
(a PRR), and has been found in an extracellular form within areas of inflammation and 476 
necrosis in human atherosclerotic lesions [79]. Therefore, its down-regulation in 477 
experimentally fed GSB could also have anti-inflammatory effects. 478 
Regarding immune-related genes, the down-regulation of three typically pro-479 
inflammatory cytokines, TNFα, IL-1β and IL-8, concurrent with the down-regulation of IL-480 
6 indicates the induction of a clear anti-inflammatory profile. In fact, IL-6 is a 481 
multifunctional, pleiotropic interleukin, with both pro- and anti-inflammatory functions 482 
[80]. In previous studies, it has been shown that in E. leei-infected GSB, IL-6, IL-8 and its 483 
receptor, IL-12 and TNFα were up-regulated short after exposure to the parasite during the 484 
inflammatory reaction [39]. Another group of genes related with immunity, PRRs, was also 485 
mainly down-regulated, especially at PI by D1 and only TLR5 and CLEC10A were equally 486 
decreased by both experimental diets. Although very few data are available on their 487 
functional regulation at the intestine or by nutrients in fish, it has been shown that TLR2, 488 
TLR4 and TLR5 can be up-regulated by feeding with probiotics [81, 82]. Some lectins 489 
induce the synthesis of pro-inflammatory cytokines, including IL1-β1, IL1-β2, TNF-α1, 490 
TNF-α2 and IL8 in rainbow trout macrophages and fibroblast-like cells [83]. The low 491 
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expression of most PRRs would be therefore in line with the observed low expression of 492 
pro-inflammatory cytokines. The only significantly up-regulated PRR, which was also the 493 
gene with the highest fold change, was fucolectin (FCL). In fact, it was significantly over-494 
expressed by D1 at both intestinal segments. Fucolectins — lectins that bind fucose— have 495 
been described as immune-recognition molecules in both invertebrates and vertebrates. 496 
They have been isolated and characterized from the sera of several fish species such as 497 
European and Japanese eels, striped bass, European sea bass and even GSB [84]. Lectins 498 
are typically multivalent proteins that recognize and bind specific carbohydrate moieties 499 
through carbohydrate recognition domains (CRD). The presence of multiple CRDs in 500 
combination with other protein domains, enable not only the recognition of carbohydrates 501 
on the surface of potential pathogens, but also on the surface of immunocompetent cells. 502 
Thus, vertebrate lectins play an active role in innate immunity, particularly in PAMP 503 
recognition, opsonisation, phagocytosis, and complement activation [85, 86]. Thus, it is 504 
tempting to suggest that those pathogens that express fucose antigens would easily be 505 
recognized by fish with increased levels of FCL, activating the corresponding cascade of 506 
immune events. In fact, Anguilla japonica fucolectin is induced by the presence of bacterial 507 
liposaccharides [87], however in E. leei-infected GSB, FCL was down-regulated [88]. As 508 
D1 fish expressed higher levels of FCL than D2 fish, we discard the possible effect of the 509 
prebiotic (rich in oligosaccharides, but with a small percentage of fucose) as the triggering 510 
agent. Further studies are needed to identify the cell types that express these high levels of 511 
FCL at AI and the possible consequences. The global down-regulation of 512 
immunosurveillance genes would be in agreement with the reported decrease of some 513 
immune factors (lysozyme, complement, immunoglobulins) by carvacrol or thymol in 514 
several fish species [32, 35]. 515 
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Most of the genes of enterocyte mass and cell epithelial activity were over-516 
expressed in experimentally fed fish. Some of them, such as FABP2, FABP6, were 517 
significantly increased at AI and PI of D2 fish, respectively, which could indicate a 518 
synergizing effect of the prebiotic. Recently, it has been shown in Atlantic salmon a 519 
progressive reduction in FABP2 staining of intestinal folds and a significant decrease of 520 
both transcriptional and protein levels of FABP2 during progression of intestinal 521 
inflammation associated to a diet induced enteritis [67]. This enteritis is characterized by 522 
increasing cell proliferation and infiltration in the lamina propria and submucosa. In 523 
addition, it has been shown that FABPs genes can be modulated by dietary fatty acids and 524 
peroxisome proliferators in zebrafish [89], as previously found in mammals [90]. 525 
Interestingly, FABP2 and FABP6 were significantly down-regulated in GSB with E. leei-526 
induced enteritis (and clinical cachexia) [88] and in blue catfish after a short-term fasting 527 
[91]. The increase in FABPs in our experimental fish was coincident with an increase in the 528 
transcripts of Enoyl-CoA hydratase (ECH) and hydroxyacyl-CoA dehydrogenase (HADH), 529 
which are enzymes essential for metabolizing fatty acids to produce both acetyl CoA and 530 
energy, as they catalyse the second and third steps, respectively, of β-oxidation in fatty acid 531 
metabolism in the mitochondrial matrix. The increase in the expression of this group of 532 
genes would be in accordance with the observed increased FGR, and probably also with the 533 
increased number of intestinal villi, enterocyte density and goblets cells in the intestine, 534 
which probably involved a higher uptake and transport of fatty acids and nutrients in 535 
general. These changes on the intestinal morphology have also been observed in red drum 536 
fed PRE [6], as well as other species of fish fed other prebiotics [92-95]. 537 
In conclusion, it appears that the combination of NE and PRE induces an anti-538 
inflammatory and anti-proliferative transcriptomic status in the intestine of GSB, mainly at 539 
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the posterior segment, and possibly changes in the absorptive capacity which would explain 540 
the observed improvement of feed conversion. These results are in agreement with those 541 
obtained for PRE in sea bass in reducing diet-induced enteritis (Peggs et al., personal 542 
communication), and with field results of the current additive combination (D2) in GSB in 543 
cage farms, in which cumulative mortality due to idiopathic enteritis was decreased 544 
(Andromeda S.A., unpublished results). Therefore, this dietary combination could have a 545 
potential use for overcoming some types of nutritionally or pathologically induced gut 546 
inflammation. In any case, the possible uses of these additives have to be further evaluated 547 
with pathogen challenges, to check if the induction of an anti-inflammatory/anti-548 
proliferative transcriptomic profile can help to alleviate the immunopathological 549 
consequences of high inflammation levels. The involvement of changes in the microbiota 550 
composition are also to be studied in the future. 551 
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Figure legends 858 
 859 
Fig. 1. Microphotographs of representative liver (A, B), anterior intestine (C, D) and 860 
posterior intestine (E, F) of gilthead sea bream fed with control  diet (A,C, E) or the D2 861 
(NE + PRE) (B, D, F). Arrowheads point to some goblet cells. Staining: Toluidine blue (A, 862 
B), H&E (C-F). Scale bars: 50 µm (A, B), 100 µm (C-F). 863 
Fig. 2. Representation of the statistically significant changed genes (P < 0.05) in the 864 
posterior (PI) and anterior (AI) intestine of gilthead sea bream fed the control diet (without 865 
additives). Bars above 0 stand for those genes with higher constitutive expression levels at 866 
the PI, and those below 0 for those more expressed at the AI. 867 
Fig. 3. Collorary of the gene expression changes found at anterior and posterior intestine of 868 
gilthead sea bream fed with diets D1 (NE) and D2 (NE + PRE). Fold changes are relative to 869 
the control diet. Red tones correspond to up-regulated genes and green tones correspond to 870 
down-regulation. The intensity of the colour represents the degree of change. Statistically 871 
significant differences between CTRL and diets groups are indicated (*P < 0.05). For each 872 
gene, the symbol and the category in which they are classified are included: 1 = cell 873 
differentiation and proliferation; 2 = Tight junctions; 3 = Cytokines; 4 = PRR; 5 = 874 
Enterocyte absorption and epithelial damage; 6 = mitochondrial activity. 875 
 876 
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Table 3. Full list of gilthead sea bream genes included in real-time PCR (in alphabetical order). The symbols of new 
sequences uploaded to GenBank are labelled in italics. 
 
Gene name Symbol Gene name Symbol 
Bone morphogenetic protein receptor type-1A BMPR1A Interleukin 8 IL-8 
Cadherin-1 CDH1 Interleukin-8 receptor A IL-8RA 
Cadherin-17 CDH17 Interleukin 10 IL-10 
Calnexin CANX Interleukin10 receptor subunit alpha IL-10RA 
Calreticulin CALR Interleukin 15 IL-15 
Catenin beta-1 CTNNB1 Interleukin 34 IL-34 
C-C chemokine receptor type 3 CCR3 Intestinal fatty acid-binding protein FABP2 
C-C chemokine receptor type 9 CCR9 Intestinal mucin I-MUC 
C-C chemokine receptor type 11 CCR11 Intestinal-type alkaline phosphatase ALPI 
C-C motif chemokine 20 CCL20 Junctional adhesion molecule A F11R 
C-C motif chemokine 25 CCL25 Krueppel-like factor 4 KLF4 
CD48 antigen CD48 Liver type fatty acid-binding protein FABP1 
CD209 antigen CD209 L-rhamnose-binding lectin CSL2 CSL2 
CD276 antigen CD276 Macrophage colony-stimulating factor 1 
receptor 1 
CSF1R1 
CD302 antigen CD302 Macrophage mannose receptor 1 MRC1 
Citrate synthase CS Mitochondrial 10 kDa heat shock protein mtHsp10 
Claudin-12 CLDN12 Mitochondrial 60 kDa heat shock protein mtHsp60 
Claudin-15 CLDN15 Mitochondrial 70 kDa heat shock preotin mtHsp70 
Coxsackievirus and adenovirus receptor homolog CXADR Mitochondrial import inner membrane 
translocase subunit 44 
Tim44 
C-type lectin domain family 10 member A CLEC10A Mitochondrial import receptor subunit 
Tom22 
Tom22 
C-X-C chemokine  CXC Mitochondrial Transcription factor A mtTFA 
Desmoplakin DSP Mucin 2 MUC2 
Enoyl-CoA hydratase ECH Mucin 2-like MUC2-
like 
Fucolectin FCL Mucin 13 MUC13 
Galectin-1 LGALS1 Notcheless protein homolog 1 NLE1 
Galectin-8 LGALS8 Nuclear respiratory factor 1 NRF1 
Gap junction beta-4 protein GJB4 Nucleotide-binding protein oligomerization 
domain-containing protein 1 
NOD1 
Gap junction Cx32.2 protein CX32.2 Occludin OCLN 
Gap junction Cx32.7 protein CX32.7 Proliferator-activated receptor gamma 
coactivator 1 alpha 
PGC1α 
Glutathione reductase GR Protein wntless homolog WLs 
Glutathione S-transferase 3 GST3 Superoxide dismutase  [Cu-Zn] SOD1 
Hedgehog-interacting protein HHIP Tight junction protein ZO-1 TJP1 
Hydroxyacyl-CoA dehydrogenase HADH Toll-like receptor 1 TLR1 
Ileal fatty acid-binding protein FABP6 Toll-like receptor 2 TLR2 
Indian hedgehog protein IHH Toll-like receptor 5 TLR5 
Integrin beta-1-binding protein 1 ITGB1BP1 Toll-like receptor 9 TLR9 
Integrin beta-6 ITGB6 Transcription factor 4 Tcf4 
Integrin-linked protein kinase ILK Transcription factor HES-1-B HES1-B 
Interleukin 1 beta IL1-β Transcriptional regulator Myc Myc 
Interleukin 1 receptor type 1 IL-1R1 Tumor necrosis factor alpha TNF-α 
Interleukin 6 IL-6 Vimentin VIM 
Interleukin 6 receptor subunit beta IL-6RB Zinc finger protein GFI-1 GFI-1 
Interleukin 7 IL-7 Zinc finger protein GLI1 GLI1 
  Zinc finger protein GLIS3 GLIS3 
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Table 1. Ingredients of the basal diet (CTRL), to which PRE (5 g/kg diet) (D2) and/or 
NE was added at 100 (D50), 200 (D100, D1), 400 (D200) or 600 (D300) mg/kg diet. 
 
Ingredient  Amount 
(g/kg) 
Fish meal (70) a 190 
Fish meal (65) b 180 
Corn gluten meal c 160 
Soybean meal d 180 
Wheat meal 142.5 
Fish oil e 140 
Monocalcium phosphate f 5 
Mineral  & vitamim premix g 2.5 
  
 
a
 Fish meal (Peruvian): 68% crude protein (CP), 9% crude fat (CF), EXALMAR, Peru. 
 
b
 Fair Average Quality (FAQ) fish meal: 63% CP, 11 % CF, COFACO, Portugal. 
 
c GLUTALYS: 61% CP, 8% CF, ROQETTE, France. 
 
d
 Solvent extracted dehulled soybean meal: 47% CP, 2.6% CF, SORGAL SA, Portugal 
 
e
 Marine oil omega 3: Henry Lamotte Oils GmbH, Germany. 
 
f
 Monocalcium phosphate: 22% phosphorous, 16% calcium, Fosfitalia, Italy. 
 
g
 Premix for marine fish, PREMIX Lda, Portugal. Vitamins (mg/kg diet, except as 
noted): DL-α tocopherol acetate, 250; sodium menadione bisulphite, 10; retinyl acetate, 
10,000 IU/kg; DL-cholecalciferol, 2,000 IU/kg; thiamine, 20; riboflavin, 20; pyridoxine, 
20; cobalamine, 0.2; nicotinic acid, 150; folic acid, 4; ascorbic acid, 300; inositol, 150; 
biotin, 0.8; calcium pantothenate, 60. Minerals (mg/kg diet): potassium iodide, 4; iron 
sulphate, 45; copper sulphate, 7; manganese oxide, 35; sodium selenite, 150; zinc oxide, 
60. 
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Table 2. Characteristics of assembled new sequences of gilthead sea bream according to BLAST searches. 
Contigs Fa Size (nt) Annotationb Best matchc Ed CDSe GenBank 
Accession No. 
C2_68236 2 669 BMPR1A CBH32481 3e-42 <1-233 KF857333 
C2_43802 6 611 IHH XP_003963214 7e-122 <1->611 KF857334 
C2_16781 22 837 GLI1 CBN80831 1e-163 <1->837 KF857336 
C2_61777 2 536 GLIS3 XP_003453957 2e-102 <1->536 KF857337 
C2_24684 19 1778 HHIP XP_003972462 2e-173 <1-822 KF857338 
C2_3167 109 2394 WLs XP_003975755 0.0 126-1766 KF857339 
C2_66983 6 595 Myc CBN82098 3e-102 <1-570 KF857340 
C2_25912 22 1809 CTNNB1 XP_003965981 0.0 <1-978 KF857341 
C2_17080 17 986 Tcf4 XP_003440245 3e-118 175->986 KF857342 
C2_32386 8 1084 NLE1 XP_003446779 0.0 83->1084 KF857343 
C2_15474 33 2081 HES1-B XP_003974264 2e-156 234-1067 KF857344 
C2_8854 7 2090 GFI-1 XP_003978426 3e-170 196-1182 KF857345 
C2_64245 2 431 KLF4 XP_003965249 6e-78 <1-353 KF857346 
C2_3381 180 1925 VIM XP_003438114 0.0 <1-973 KF857332 
C2_1720 145 1987 ITGB1BP1 XP_004082307 3e-95 98-694 KF861987 
C2_26407 14 1397 ITGB6 XP_008283045 5e-107 <1-669 KF861988 
C2_2296 148 2884 ILK XP_003968610 0 183-1541 KF861989 
C2_15809 32 1077 OCLN XP_003445179 0 <1->1077 KF861990 
C2_10139 87 2435 CLDN12 AAT64072 5e-153 210-1241 KF861992 
C2_218 1275 1485 CLDN15 XP_004079873 2e-137 176-844 KF861993 
C2_57261 6 708 TJP1 XP_008288986 3e-104 <3->708 KF861994 
C2_2045 4026 230 CDH1 CAF91005 0 193-2901 KF861995 
C2_3038 169 3092 CDH17 XP_004078163 0 75-2666 KF861996 
C2_1814 296 2334 F11R XP_003971293 4e-126 198-1100 KF861997 
C2_12148 39 1210 CXADR XP_003978491 4e-163 <1-894 KF861998 
C2_20476 32 2019 DSP CAG07577 0 <1-1917 KF861999 
C2_501 648 1391 CX32.2 P51915 0 131-991 KF862000 
C2_7763 52 1557 CX32.7 XP_005737265 3e-164 326-1222 KF862001 
C2_79555 888 4 GJB4 XP_003962600 8e-98 50-556 KF862002 
C2_2049 370 1912 ALPI XP_003974329 0.0 88-1656 KF857309 
C2_23355 21 1187 FABP1 Q8JJ04 7e-68 169-552 KF857311 
C2_1175 972 1474 FABP2 ACI68448 6e-79 64-462 KF857310 
C2_750 460 696 FABP6 XP_003975579 2e-78 205-588 KF857312 
C2_1023 720 1920 CALR ABG00263 0.0 101-1350 KF857313 
C2_19770 27 1558 CANX ADX97134 0.0 <1-1266 KF857314 
C2_11437 63 842 CXC ACQ59055 4e-45 36-452 KF857315 
C2_6505 202 1043 CCL25 XP_003448528 3e-36 111-443 KF857316 
C2_1992 154 1295 CCR3 BAC87713 0.0 119-1219 KF857317 
C2_3514 136 1901 CCR9 CBJ23501 0.0 252-1358 KF857318 
C2_18315 44 1454 CCR11 CBN82022 0.0 121-1233 KF857319 
C2_6437 83 1665 CD48 ACQ58805 3e-48 125-949 KF857320 
C2_43130 10 1136 CD276 NP_001177294 7e-141 77-973 KF857321 
C2_13781 16 1188 TLR1 ADX01348 0.0 <1->1188 KF857322 
C2_12348 52 2293 TLR2 AFZ81806 0.0 <1-2115 KF857323 
C2_20508 30 2076 TLR5 AEN71825 0.0 <1-1695 KF857324 
C2_14384 25 1303 NOD1 AFV53357 0.0 125->1303 KF857325 
C2_1940 246 3462 MRC1 XP_008284986 0.0 <1-3045 KF857326 
C2_1976 149 1531 CD209 XP_003966073 4e-94 71-844 KF857327 
C2_4689 179 3364 CD302 XP_003962014 7e-81 102-857 KF857328 
C2_27915 9 1079 CLEC10A XP_003446031 5e-126 57-953 KF857329 
C2_111 990 1324 LGALS1 ADV35589 8e-74 312-719 KF862003 
C2_12854 25 1564 LGALS8 AFJ79965 4e-142 56-997 KF862004 
C2_2032 263 1244 CSL2 XP_003455367 4e-103 40-708 KF857330 
C2_1599 588 1822 FCL XP_003450311 2e-154 110-1042 KF857331 
aNumber of reads composing the assembled sequences. 
bGene identity determined through BLAST searches; full name of the genes can be found in table 3. 
cBest BLAST-X protein sequence match (lowest E value). 
dExpectation value. 
eCodifying sequence. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 4. Dose-dependent effects of NE (0-300 ppm) on the growth performance, haematological parameters, plasma 
biochemistry, total antioxidant capacity (TAC) and respiratory burst (RB) of gilthead sea bream juveniles fed to visual 
satiety for 9 weeks (Trial 1). Data on body weight, feed intake, and growth indices are the mean (S.E.M) of triplicate 
tanks. Data on viscera and liver weight are the mean (S.E.M) of 20-25 fish and the remaining values are the mean (S.E.M) 
of 8-10 fish. Different superscript letters in each row indicate significant differences among dietary treatments (ANOVA-I 
followed by Student Newman-Keuls test, P < 0.05). 
 
 
1 Viscerosomatix index = (100 x viscera weight) / fish weight 
2 Hepatosomatic index = (100 x liver weight) / fish weight 
3 Splenosomatic index = (100 x spleen weight) / fish weight 
4 Specific growth rate = 100 x (ln final body weight - ln initial body weight / days) 
5 Feed gain ratio = dry feed intake / wet weight gain  
6 Of circulating leukocytes after PMA stimulation 
 CTRL D50 D100 D200 D300 P 
Initial body weight(g) 27.2(0.019) 27.0(0.45) 27.1(0.25) 27.0(0.55) 27.1(0.12) 0.97 
Final body weight (g) 96.7(2.53) 92.5(0.28) 91.6(0.31) 90.8(0.86) 88.4(1.31) 0.098 
Feed intake (g DM/fish) 75.2(3.96)a 63.9(0.67)b 62.9(2.24)b 62.4(0.06)b 58.6(1.99)b 0.033 
Viscera (g) 8.16(0.29)a 7.70(0.25)ab 7.15(0.25)ab 7.25(0.28)ab 6.65(0.23)b 0.003 
Liver (g) 1.30(0.06)a 1.22(0.06)ab 1.12(0.03)ab 1.15(0.05)ab 1.13(0.01)b 0.045 
Spleen (g) 0.19(0.02) 0.19(0.02) 0.17(0.04) 0.15(0.02) 0.13(0.01) 0.057 
VSI (%)1 8.21(0.16)a 8.14(0.15)ab 7.99(0.13)ab 7.82(0.18)ab 7.57(0.12)b 0.030 
HI (%)2 1.32(0.04) 1.29(0.05) 1.25(0.02) 1.26(0.05) 1.29(0.04) 0.76 
SI (%)3 0.19(0.03)a 0.20(0.02)a 0.19(0.04)ab 0.17(0.01)ab 0.14(0.004)b 0.005 
SGR (%)4 2.04(0.03) 2.02(0.02) 2.00(0.02) 1.99(0.02) 1.94(0.03) 0.16 
FGR (%)5 1.08(0.038)a 0.97(0.01)b 0.97(0.04)b 0.97(0.005)b 0.96(0.05)b 0.047 
Haemoglobin (g/dl) 8.90(0.44) 8.97(0.28) 8.6(0.15) 8.57(0.25) 8.63(0.18) 0.249 
Proteins (g/dl) 3.59(0.13) 3.70(0.14) 3.76(0.09) 3.62(0.12) 3.67(0.11) 0.790 
TG (mM/l) 0.38(0.04) 0.32(0.04) 0.35(0.03) 0.32(0.05) 0.33(0.04) 0.877 
Cholesterol (mg/dl) 176.3(12.9) 157.7(14.6) 140.5(19.4) 136.5(11.2) 159.7(11.5) 0.156 
Glucose (mg/dl) 50.1(4.01) 50.6(3.06) 49.2(2.21) 53.1(1.31) 49.5(1.91) 0.207 
TAC (mM Trolox) 1.99(0.07) 1.92(0.04) 2.00(0.08) 1.86(0.06) 1.85(0.07) 0.411 
RB (RLU)6 14431.9 (2353.8) 9737.5 (3048.6) 12877.5(4004.3) 17920(4287.8) 26282.5(12080.6) 0.297 
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Table 5. Effects of NE (100 ppm) alone (D1) or in combination with PRE (0.5%) (D2), in comparison 
to the control diet (CTRL) on performance of gilthead sea bream juveniles (Trial 2). Data are the mean 
(S.E.M) of triplicated tanks. Different superscript letters in each row indicate significant differences 
among dietary treatments ANOVA-I followed by Student Newman-Keuls test (P < 0.05). 
 
 
1Specific growth rate = 100 x (ln final body weight - ln initial body weight / days) 
2Feed gain ratio = dry feed intake / wet weight gain  
3
 Total antioxidant capacity 
 
 CTRL D1 D2 P 
Initial body weight (g) 24.2 (0.54) 24.4 (0.13) 24.9 (0.01) 0.39 
Final body weight (g) 102.7 (2.86) 103.08 (1.18) 100.5 (3.95) 0.811 
Feed intake (g/fish) 87.9 (1.7)a 75.5 (3.35)ab 71.3 (0.99)b 0.028 
SGR (%)1 1.97 (0.06) 1.97 (0.008) 1.91 (0.05) 0.613 
FGR (%)2 1.12 (0.027)b 0.96 (0.029)a 0.94 (0.036)a 0.048 
Haemoglobin (g/dl) 9.52(0.24) 8.92(0.45) 8.91(0.72) 0.632 
TAC (mM Trolox)3 1.18(0.08) 1.14(0.09) 1.24(0.05) 0.652 
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 Figure 3. 
 
GENE  ANTERIOR INTESTINE POSTERIOR INTESTINE 
Category Symbol D1 D2 D1 D2 
1 BMPR1A 1.08 0.96 0.85 0.75* 
 GLI1 0.90 0.81 0.73* 0.82 
 WLs 0.80 0.93 0.65* 0.86 
 Myc 0.92 0.92 0.64* 0.78 
 Tcf4 0.77 0.79 0.57* 0.72 
 VIM 0.89 0.99 0.65* 0.62* 
2 CLDN12 0.91 0.80 0.76* 0.75* 
 CLDN15 0.90 0.98 0.78 0.73* 
 TJP1 0.84 0.85 0.68* 0.69* 
 GJB4 0.87 0.86 0.65* 0.71* 
3 IL-1β 0.47* 0.64* 0.64 0.68 
 IL-6 0.23* 0.39* 0.12* 0.25* 
 IL-8 0.74 0.38* 0.95 0.67 
 TNFα 0.92 0.81 0.76 0.64* 
4 TLR1 0.69 0.92 0.72* 0.95 
 TLR5 0.53 0.67 0.55* 0.60* 
 TLR9 1.14 0.80 0.57* 0.91 
 CLEC10A 0.68 0.79 0.53* 0.60* 
 LGALS1 0.94 1.14 0.69* 0.93 
 FCL 11.7* 3.34 6.12* 3.33 
5 ALPI 1.09 0.45* 0.91 0.72 
 FABP2 1.57 3.33* - - 
 FABP6 
- - 1.52* 2.45* 
 CANX 1.02 0.81 0.85 0.77* 
6 ECH 1.98* 1.55* 1.21 1.28 
 HADH 1.51* 1.16 1.30 1.01 
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Highlights  
 54 new intestinal-related gene sequences were identified 
 More than half of the studied genes was more expressed at the posterior intestine 
 The additives improved feed gain ratio  
 The additives induced more changes in the transcriptome of posterior intestine 
 The additives induced an anti-inflammatory and anti-proliferative transcriptomic profile 
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Supplementary Table 2. Forward and reverse primers of gilthead sea bream genes for real-time 
PCR. The symbols of new sequences uploaded to GenBank are labelled in italics 
 
Gene name Symbol  Primer sequence 
Bone morphogenetic protein receptor 
type-1A 
BMPR1A F AGT GCT GGG CTC ATA ACC 
 
R CAT CTT GGC GAG TGT CTT CT 
Indian hedgehog protein 
 
IHH F ACA GGT TGG CTA TCG CAG TG 
 
R CCT CCG TCA CAC GCA AGT 
Zinc finger protein GLI1 GLI1 F AGA ACC AGC GAG GAA TGC CGT ATT 
 
R TTG AAG TGG GTC GGT GTC TGT TGA TT 
Zinc finger protein GLIS3 GLIS3 F CGA CAG TTG CGG AAG AAG ATG 
 
R AGG GTG GAT GGT TAA ACA GTC T 
Hedgehog-interacting protein HHIP F CTG TGT AAG AGC GGC TAC T 
 
R CCT GGT CGT TGG GCA TAC 
Protein wntless homolog WLs F GAG GTC GGC AGC GTG GCT CAT AAG TA 
 
R GTT GAC AGG CAG ACG GAT GTT GAG AAG GT 
Transcriptional regulator Myc Myc F CAG CAG CAA CCG CAA GTG T 
R TGT CGT AGT CCT CCG TGT CAG A 
Catenin beta-1 CTNNB1 F ACA CAG AGA CGC ACC AGC AT 
 
R CTC CAT ACG AAC TCC CTC CAC AAA 
Transcription factor 4 Tcf4 F CAG AGA GCC CAA CCC ACA CT 
 
R CCC AAC TCG CCA CCC AGT AT 
Notcheless protein homolog 1 NLE1 F GGA CTT GAC GAC GGA GAC 
 
R ACC AGG CGA TGC TCA GTA 
Transcription factor HES-1-B HES1-B F GCC TGC CGA TAT GAT GGA A 
 
R GGA GTT GTG TTC ATG CTT GC 
Zinc finger protein GFI-1 GFI-1 F CTC AGC AGC CTC TGG ACT 
 
R GCA GTG GTA GGT GTT GGA G 
Krueppel-like factor 4 KLF4 F ACA TCA CCG CAC GCA CAC 
 
R AAC CAC AGC CCT CCC AGT C 
Vimentin VIM F GCT TCA GAC AGG ATG TGG ACA AC 
  
R AGT GAT TCT ACC TTC CGC TCC AG 
Integrin beta-1-binding protein 1 ITGB1BP1 F GCC ACC CTC TCT ACC TGA TAG T 
 
R TTG AGA GCC AGG AGG TTC TTC 
Integrin beta-6 ITGB6 F AGC CTC CCA ACA TCC CTA TGA TTA TTC 
 
R CTT CCA CAC ACC CAG CAG AA 
Integrin-linked protein kinase ILK F GCC AAT GAA CAC GGG AAC AC 
 
R ACG AGA TCC TCA GCC ACT TG 
Occludin OCLN F GTG TCA GAA CCT CTA CCA GAC CAG CTA 
CTC 
 
R GAA AGC CTC CCA CTC CTC CCA TCT 
Claudin-12 CLDN12 F CTC TCA GGG CTA CAC ATC TAC CTA TGC 
 
R ACA TTC GTG AGC GGC TGG AG 
Claudin-15 CLDN15 F CCG ATT GTG GAA GTA GTG GCT CTG GT 
 
R CAG CAT CAC CCA ACC GAC GAA CC 
Tight junction protein ZO-1 TJP1 F AAG CAG TAT TAC GGT GAC TCA 
 
R TGC ATC CCT GGC TTG TAG 
Cadherin-1 CDH1 F TGC TCC ATA CAG CGT CAC CTT ACA 
 
R CTC GTT CAT CCT AGC CGT CCA GTT 
Cadherin-17 CDH17 F GAT GCC CGC AAC CCA GAG 
 
R CCG TTG ATT CAC TGC CGT AGA C 
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 Supplementary Table 2. Continued-I 
Gene name Symbol  Primer sequence 
Junctional adhesion molecule A F11R F GAC TGG TTT CGG TGG CTT TGT TC 
 
R TGG CTT GGG AGG TAG TGA CTG TA 
Coxsackievirus and adenovirus 
receptor homolog 
CXADR F CAT CAG AGG ACT ACG AGA GG 
 
R CAT CTT GGC AGC ATT TGG T 
Desmoplakin DSP F GCA GAA GGA GCA CGA GAC CATC 
 
R GGG TGT TCT TGT CGC AGG TGA A 
Gap junction Cx32.2 protein CX32.2 F CGA GGT GTT CTA TCT GCT CTG TA 
 
R CTT GTG GGT GCG AGT CCT 
Gap junction Cx32.7 protein CX32.7 F CGC TCA CCT TGC CCT CAC AA 
 
R AAC CAG ATG ATG ACC GAC TTC TCT 
Gap junction beta-4 protein GJB4 F TGA AAT CCT CTA CCT GGT CGG CAA AC 
 
R TGG CGA GAA TTA TGG AAC GAG GTG AAG 
Mucin 2 MUC2 F ACG CTT CAG CAA TCG CAC CAT 
 
R CCA CAA CCA CAC TCC TCC ACA T 
Mucin 2-like MUC2-like F GTG TGT GGC TGT GTT CCT TGC TTT GT 
 
R GCG AAC CAG TCT GGC TTG GAC ATC A 
Mucin 13 MUC13 F TTC AAA CCC GTG TGG TCC AG 
 
R GCA CAA GCA GAC ATA GTT CGG ATA T 
Intestinal mucin I-MUC F GTG TGA CCT CTT CCG TTA 
 
R GCA ATG ACA GCA ATG ACA 
Intestinal-type alkaline phosphatase ALPI F CCG CTA TGA GTT GGA CCG TGA T 
 
R GCT TTC TCC ACC ATC TCA GTA AGG G 
Liver type fatty acid-binding protein FABP1 F GTC CTC GTC AAC ACC TTC ACC AT 
 
R CGC CTT CAT CTT CTC GCC AGT 
Intestinal fatty acid-binding protein FABP2 F CGA GCA CAT TCC GCA CCA AAG 
 
R CCC ACG CAC CCG AGA CTT C 
Ileal fatty acid-binding protein FABP6 F ACC CAG GAC GGC AAT ACC 
 
R CGA CGG TGA AGT TGT TGG T 
Calreticulin CALR F GGC GGC GGC TAT GTG AAG 
 
R GCA TCG CAG TCT GAT CCA AGT C 
Calnexin CANX F CCC GAG GGT TGG CTA GAT GA 
 
R GGC GTC TGG GTC TCC GAT AT 
Glutathione reductase GR F TGT TCA GCC ACC CAC CCA TCG G 
 R GCG TGA TAC ATC GGA GTG AAT GAA GTC TTG 
Glutathione S-transferase 3 GST3 F CCA GAT GAT CAG TAC GTG AAG ACC GTC 
  R CTG CTG ATG TGA GGA ATG TAC CGT AAC 
Superoxide dismutase  [Cu-Zn] SOD1 F TCA CGG ACA AGA TGC TCA CTC TC 
 R GGT TCT GCC AAT GAT GGA CAA GG 
Interleukin 1 beta IL1-β F GCGACCTACCTGCCACCTACACC 
 
R TCG TCC ACC GCC TCC AGA TGC 
Interleukin 1 receptor type 1 IL-1R1 F GAA GCT GTA CGA CGC CTA C 
 
R CTC CAC TGC CTT ACT GTA TCC 
Interleukin 6 IL-6 F TCT TGA AGG TGG TGC TGG AAG TG 
 
R AAG GAC AAT CTG CTG GAA GTG AGG 
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Supplementary Table 2. Continued-II 
Gene name Symbol  Primer sequence 
Interleukin 6 receptor subunit beta IL-6RB F CAG TGT CGG AGT ATG TGG TTG AGT 
 
R CCC TCT GCC AGT CTG TCC AA 
Interleukin 7 IL-7 F CTA TCT CTG TCC CTG TCC TGT GA 
  
TGC GGA TGG TTG CCT TGT AAT 
Interleukin 15 IL-15 F GAG ACC AGC GAG CGA AAG GCA TCC 
 
R GCC AGA ACA GGT TAC AGG TTG ACA GGA A 
Interleukin 8 IL-8 F CAG CAG AGT CTT CAT CGT CAC TAT TG 
 
R AGG CTC GCT TCA CTG ATG G 
High affinity interleukin-8 receptor A IL-8RA F CTT GTT TCA TCT GAC GAT AG 
 
R AAG AGG ATG CTT GTG TAG 
Interleukin 10 IL-10 F AAC ATC CTG GGC TTC TAT CTG 
 
R GTG TCC TCC GTC TCA TCT G 
Interleukin10 receptor subunit alpha IL-10RA F GAG GAC AAT GAA GAG GAA GAC AGG AG 
 
R TGT TCG TAG CGG AGT TGG ACT 
Interleukin 34 IL-34 F TCT GTC TGC CTG CTG GTA G 
 
R ATG CTG GCT GGT GTC TGG 
Tumor necrosis factor alpha TNF-α F CAGGCGTCGTTCAGAGTCTC 
 
R CTGTGGCTGAGAGGTGTGAG 
Macrophage colony-stimulating factor 
1 receptor 1 
CSF1R1 F TTG CGT GTG GTG AGG AAG GAA GGT 
 
R AGC AGG CAG GGC AGC AGG TA 
C-X-C chemokine  CXC F CTG AGG AGT AAC GAG ACA GTG TG 
 
R CCT GTT CCA GCA GCG TAT CA 
C-C motif chemokine 25 CCL25 F GCA ACA TCC CTG CCA CAA TCT TCA 
 
R TCC TTC AGT TCT ATG ACC CAC ATC TCT C 
C-C chemokine receptor type 3 CCR3 F CTA CAT CAG CAT CAC CAT ACG CAT CCT 
 
R TGG CAC GGC ACT TCT CCT TCA 
C-C chemokine receptor type 9 CCR9 F TCC CTG AGT TAA TCT TCG CCC AAG TG 
 
R TGT TGT ATT CGT TGT TCC AGT AGA CCA GAG 
C-C chemokine receptor type 11 CCR11 F GCT ACG ATT ACA GTT ATG AA 
 
R TAG ATG ATT GGG AGG AAG 
C-C motif chemokine 20 CCL20 F CCG TCC TCA TCT GCT TCA TAC T 
 
R GCT CTG CCG TTG ATG GAA C 
CD48 antigen CD48 F GAC ATA CTT CGA GGT TGG CGG TAA ACT 
 
R GAT GTT GTC GAT AGT CTC CGT CAC TGT AGG 
CD276 antigen CD276 F GTC ACA CTC AAC TGC TCC TTC A 
 
R CGC CAG AAG ACG GTC AGA T 
Toll-like receptor 1 TLR1 F GGG ACC TGC CAG TGT GTA AC 
 
R GCG TGG ATA GAG TTG GAC TTG AG 
Toll-like receptor 2 TLR2 F CAT CTG CGA CTC TCC TCT CTT CCT 
 
R ATT CAA CAA TGG AGC GGT GGA CTT 
Toll-like receptor 5 TLR5 F TCG CCA ATC TGA CGG ACC TGA G 
 
R CAG AAC GCC GAT GTG GTT GTA AGA C 
Toll-like receptor 9 TLR9 F GCC TTC CTT GTC TGC TCT TTC T 
 
R GCC GTA GAG GTG CTT CAG TAG 
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 Supplementary Table 2. Continued-III 
Gene name Symbol  Primer sequence 
Nucleotide-binding protein 
oligomerization domain-containing 
protein 1 
NOD1 F GTC CAG GTT GAG GAG CAT CCA GTG 
 
R TGA AGC CAC AAG CCG ACA GGT T 
 
 
 
Macrophage mannose receptor 1 MRC1 F CTT CCG ACC GTA CCT GTA CCT ACT CA 
 
R CGA TTC CAG CCT TCC GCA CAC TTA 
CD209 antigen CD209 F CGC CAC GAG CAT GAG GAC AA 
 
R TCT TGC CAG AAT CCA TCA CCA TCC A 
CD302 antigen CD302 F GGA CCA GAG GAA GAG CAC ATC 
 
R GAC CAG GGC GGA CAT CAG 
C-type lectin domain family 10 member 
A 
CLEC10A F CGA CTC TGG ACT CCC TCA 
 
R CGT TGT TGA TGG TGC GTT C 
Galectin-1 LGALS1 F GTG TGA GGA GGT CCG TGA TG 
 
R ACT GTA GAG CCG TCC GAT AGG 
Galectin-8 LGALS8 F GGC GGT GAA CGG CGG TCA 
 
R GCT CCA GCT CCA GTC TGT GTT GAT AC 
L-rhamnose-binding lectin CSL2 CSL2 F GCT CAC CAA TAC AAA GTG CTC TCA G 
 
R CTT GCC ATC ACA CCT CCT CCT 
Fucolectin FCL F CCA TAC TGC TGA ACA GAC CAA CC 
 
R TGA TGG AGG TGA CGA TGT AGG A 
Mitochondrial 10 kDa heat shock protein mtHsp10 F CAT GCT GCC AGA GAA GTC TCA AGG 
 R AGG TCC CAC TGC CAC TAC TGT 
Mitochondrial 60 kDa heat shock protein mtHsp60 F TGT GGC TGA GGA TGT GGA TGG AGA G 
 R GCC TGT TGA GAA CCA AGG TGC TGA G 
Mitochondrial 70 kDa heat shock preotin mtHsp70 F TCC GGT GTG GAT CTG ACC AAA GAC 
 R TGT TTA GGC CCA GAA GCA TCC ATG 
Enoyl-CoA hydratase ECH F GCC CAA GAA GCC AAG CAA TCA G 
 R CTT TAG CCA TAG CAG AGA CCA GTT TG 
Hydroxyacyl-CoA dehydrogenase HADH F GAA CCT CAG CAA CAA GCC AAG AG 
 R CTA AGA GGC GGT TGA CAA TGA ATC C 
Citrate synthase CS F TCC AGG AGG TGA CGA GCC 
 R GTG ACC AGC AGC CAG AAG AG 
Mitochondrial import inner membrane 
translocase subunit 44 
Tim44 F GAT GAC CTG GGA CAC ACT GG 
 R TCA CTC CTC TTC CTG AGT CTG G 
Mitochondrial import receptor subunit 
Tom22 
Tom22 F CGC TCT GGG TGG GTA CTA CCT CCT T 
 R CGA ACA CAA CAG GCA GCA CCA GGA T 
Mitochondrial Transcription factor A mtTFA F GAG CCC GCA ACA GAA ACA GCC ATT 
 R ACT GCT CCC TGT CCC GCT GAT AG 
Nuclear respiratory factor 1 NRF1 F CAG ATA GTC CTG GCA GAG A 
 R GAC CTG TGG CAT CTT GAA 
Proliferator-activated receptor gamma 
coactivator 1 alpha 
PGC1α F CGT GGG ACA GGT GTA ACC AGG ACT C 
 R ACC AAC CAA GGC AGC ACA CTC TAA TTC T 
  
 
β-actin ACTB F TCC TGC GGA ATC CAT GAG A 
 
R GAC GTC GCA CTT CAT GAT GCT 
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 Supplementary Table 1. PCR-array layout of 87 genes of gilthead sea bream with extra-wells for housekeeping 
genes and general controls of PCR performance.  
 
  
 1 2 3 4 5 6 7 8 9 10 11 12 
A BMPR1A Tcf4 ILK CXADR I-MUC GST3 IL8 CCL25 TLR2 LGALS1 HADH PPC1 
B IHH NLE1 OCLN DSP ALPI SOD1 IL8RA CCR3 TLR5 LGALS8 CS PPC2 
C GLI1 HES1-B CLDN12 CX32.2 FABP1 IL1β IL10 CCR9 TLR9 CSL2 Tim44 PPC3 
D GLIS3 GFI-1 CLDN15 CX32.7 FABP2 IL1R1 IL10RA CCR11 NOD1 FCL Tom22 PPC4 
E HHIP KLF4 TJP1 GJB4 FABP6 IL6 IL34 CCL20 MRC1 mtHsp10 mtTFA NPC 
F WLs VIM CDH1 MUC2 CALR IL6RB TNFα CD48 CD209 mtHsp60 NRF1 NPC 
G Myc ITGB1BP1 CDH17 MUC2-like CANX IL7 CSF1R1 CD276 CD302 mtHsp70 PGC1α ACTB 
H CTNNB1 ITGB6 F11R MUC13 GR IL15 CXC TLR1 CLEC10A ECH  ACTB 
Position Symbol Description Accession No. 
A1 BMPR1A Bone morphogenetic protein receptor type-1A KF857333 
B1 IHH Indian hedgehog protein KF857334 
C1 GLI1 Zinc finger protein GLI1 KF857336 
D1 GLIS3 Zinc finger protein GLIS3 KF857337 
E1 HHIP Hedgehog-interacting protein KF857338 
F1 WLs Protein wntless homolog KF857339 
G1 Myc Transcriptional regulator Myc KF857340 
H1 CTNNB1 Catenin beta-1 KF857341 
A2 Tcf4 Transcription factor 4 KF857342 
B2 NLE1 Notcheless protein homolog 1 KF857343 
C2 HES1B Transcription factor HES-1-B KF857344 
D2 GFI-1 Zinc finger protein GFI-1 KF857345 
E2 KLF4 Krueppel-like factor 4 KF857346 
F2 VIM Vimentin KF857332 
G2 ITGB1BP1 Integrin beta-1-binding protein 1 KF861987 
H2 ITGB6 Integrin beta-6 KF861988 
A3 ILK Integrin-linked protein kinase KF861989 
B3 OCLN Occludin KF861990 
C3 CLDN12 Claudin 12 KF861992 
D3 CLDN15 Claudin 15 KF861993 
E3 TJP1 Tight junction protein ZO-1 KF861994 
F3 CDH1 Cadherin 1 KF861995 
G3 CDH17 Cadherin 17 KF861996 
H3 F11R Junctional adhesion molecule A KF861997 
A4 CXADR Coxsackievirus and adenovirus receptor homolog KF861998 
B4 DSP Desmoplakin KF861999 
C4 CX32.2 Gap junction Cx32.2 protein KF862000 
D4 CX32.7 Gap junction Cx32.7 protein KF862001 
E4 GJB4 Gap junction beta-4 protein KF862002 
F4 MUC2 Mucin 2 JQ27710 
G4 MUC2-like Mucin 2-like JQ27711 
H4 MUC13 Mucin 13 JQ27713 
A5 I-MUC Intestinal mucin JQ27712 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Supplementary Table 1. Continued-I. 
 
 
Position Symbol Description Accession No. 
B5 ALPI Intestinal-type alkaline phosphatase KF857309 
C5 FABP1 Liver type fatty acid-binding protein KF857311 
D5 FABP2 Intestinal fatty acid-binding protein KF857310 
E5 FABP6 Ileal fatty acid-binding protein KF857312 
F5 CALR Calreticulin KF857313 
G5 CANX Calnexin KF857314 
H5 GR Glutathione reductase AJ937873 
A6 GST3 Glutathione S-transferase 3 JQ308828 
B6 SOD1 Superoxide dismutase  [Cu-Zn], cytoplasmatic JQ308833 
C6 IL-1β Interleukin 1 beta AJ419178 
D6 IL-1R1 Interleukin 1 receptor type 1 JX976615 
E6 IL-6 Interleukin 6 EU244588 
F6 IL-6RB Interleukin 6 receptor subunit beta JX976617 
G6 IL-7 Interleukin 7 JX976618 
H6 IL-15 Interleukin 15 JX976625 
A7 IL-8 Interleukin 8 JX976619 
B7 IL-8RA High affinity interleukin-8 receptor A JX976620 
C7 IL-10 Interleukin 10 JX976621 
D7 IL-10RA Interleukin10 receptor subunit alpha JX976621 
E7 IL-34 Interleukin 34 JX976629 
F7 TNF-α Tumor necrosis factor alpha AJ413189 
G7 CSF1R1 Macrophage colony-stimulating factor 1 receptor 1 AM050293 
H7 CXX C-X-C chemokine KF857315 
A8 CCL25 C-C motif chemokine 25 KF857316 
B8 CCR3 C-C chemokine receptor type 3 KF857317 
C8 CCR9 C-C chemokine receptor type 9 KF857318 
D8 CCR11 C-C chemokine receptor type 11 KF857319 
E8 CCL20 C-C chemokine CK8 GU181393 
F8 CD48 CD48 antigen KF857320 
G8 CD276 CD276 antigen KF857321 
H8 TLR1 Toll-like receptor 1 KF857322 
A9 TLR2 Toll-like receptor 2 KF857323 
B9 TLR5 Toll-like receptor 5 KF857324 
C9 TLR9 Toll-like receptor 9 AY751797 
D9 NOD1 Nucleotide-binding protein oligomerization domain-
containing protein 1 
KF857325 
E9 MRC1 Macrophage mannose receptor 1 KF857326 
F9 CD209 CD209 antigen KF857327 
G9 CD302 CD302 antigen KF857328 
H9 CLEC10A C-type lectin domain family 10 member A KF857329 
A10 LGALS1 Galectin-1 KF862003 
B10 LGALS8 Galectin-8 KF862004 
C10 CSL2 L-rhamnose-binding lectin CSL2 KF857330 
D10 FCL Fucolectin KF857331 
E10 mtHsp10 Mitochondrial 10 kDa heat shock protein JX975224 
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Supplementary Table 1. Continued-II. 
 
Cell differentiation and proliferation (14): BMP pathway (BMPR1A), Hh pathway (IHH, GLI1, GLIS3), Wnt 
pathway (HHIP, WLs, Myc, CTNNB1, Tcf4), Notch pathway (NLE1, HES1-B, GFI-1, KLF4), VIM. 
Intestinal architecture and permeability (19): ITGB1BP1, ITGB6, ILK, OCLN, CLDN12, CLDN15, TJP1, 
CDH1, CDH17, F11R, CXADR, DSP, CX32.2, CX32.7, GJB4, MUC2, MUC2-like, MUC13, I-MUC. 
Enterocyte mass and epithelia damage (9): ALPI, FABP1, FABP2, FABP6, CALR, CANX, GR, GST3, SOD1. 
Interleukines, cytokines and chemokine receptors (21): IL-1β, IL-1R1, IL-6, IL-6RB, IL-7, IL-15, IL-8, IL-
8RA, IL-10, IL-10RA, IL-34, TNF-α, CSF1R1, CXC, CCL25, CCR3, CCR9, CR11, CCL20, CD48, CD276. 
Pattern recognition receptors (13): TLR1, TLR2, TLR5, TLR9, NOD1, MRC1, CD209, CD302, CLEC10A, 
LGALS1, LGALS8, CSL2, FCL. 
Mitochondria function and biogenesis (11): mtHsp10, mtHsp60, mtHsp70, ECH, HADH, CS, Tim44, Tim22, 
mtTFA, NRF1, PGC1α.  
 
 
Position Symbol Description Accession No. 
F10 mtHsp60 Mitochondrial 60 kDa heat shock protein JX975227 
G10 mtHsp70 Mitochondrial 70 kDa  heat shock protein DQ524993 
H10 ECH Enoyl-CoA hydratase JQ308826 
A11 HADH Hydroxyacyl-CoA dehydrogenase JQ308829 
B11 CS Citrate synthase JX975229 
C11 Tim44 Mitochondrial import inner membrane translocase subunit 44 JX975239 
D11 Tom22 Mitochondrial import receptor subunit Tom22 JX975236 
E11 mtTFA Mitochondrial transcription factor A JX975262 
F11 NRF1 Nuclear respiratory factor 1 JX975263 
G11 PGC1α Proliferator-activated receptor gamma coactivator 1 alpha JX975264 
A12-D12 PPC Positive PCR control (serial dilutions of standard gene) AY590304 
E12/F12 NPC Negative PCR control   
G12/H12 ACTB ß-Actin X89920 
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Supplementary Table 3. Gene expression profile of interior and posterior intestine sections in gilthead sea 
bream fed CTRL and experimental diets D1 (NE150) and D2 (NE150 + Previda). Values are the mean ± 
S.E.M. (n = 6). Rows with unlike superscript letters were significantly different (P < 0.05; Student-Newman-
Keuls). β-actin was used as a housekeeping gene and all data values are referred to the expression level of IL-
1β in CTRL fish (arbitrary value of 1). 
 
Gene name 
Anterior intestine  Posterior intestine  ANOVA 
CTRL D1 D2  CTRL D1 D2  P-value 
BMPR1A 28.8±1.2b 31.1±2.2b 27.8±3.1b  42.8±3.7a 36.4±5.2ab 32.2±2.1b  0.031 
IHH 2.4±0.62a 2.2±0.28a 2.3±0.63a  0.39±0.12b 0.2±0.03b 0.14±0.01b  <0.001 
GLI1 5.0±0.43ab 4.5±0.25b 4.0±0.42b  6.2±0.55a 4.5±0.4b 5.1±0.43ab  0.021 
GLIS3 0.62±0.15 0.56±0.20 0.56±0.13  0.3±0.16 0.3±0.09 0.23±0.08  0.256 
HHIP 16.4±1.6b 17.4±1.5b 18.2±3.0b  43.3±10.5a 37.5±5.2ab 30.3±2.8ab  0.003 
WLs 7.7±0.63c 6.1±0.30c 7.1±0.85c  17.3±2.1a 11.3±0.97b 14.9±0.94a  <0.001 
Myc 3.3±0.43b 3.1±0.29b 3.1±0.53b  7.0±1.1a 4.4±0.65b 5.4±0.53ab  0.001 
CTNNB1 127.4±10.3 107.7±4.8 100.0±3.3  135.8±11.5 111.8±9.7 117.9±9.5  0.075 
Tcf4 1.3±0.10cd 1.0±0.09d 1.1±0.21d  3.2±0.28a 1.8±0.23bc 2.3±0.19b  <0.001 
NLE1 6.6±0.71a 6.4±0.63ab 6.1±1.0ab  3.7±0.28b 4.1±0.63ab 4.3±0.44ab  0.011 
HES1 80.2±10.3 78.1±10.6 64.4±7.7  112.9±13.6 110.8±19.0 88.8±10.4  0.064 
GFI-1 0.49±0.05 0.70±0.04 0.59±0.07  0.62±0.08 0.5±0.07 0.6±0.07  0.378 
KLF4 20.9±2.0 21.1±1.9 19.7±1.6  19.4±3.9 17.5±4.1 18.0±2.4  0.936 
VIM 5.1±0.67b 4.6±0.57b 5.1±1.1b  12.1±0.66a 7.9±0.98b 7.6±1.2b  <0.001 
ITGB1BP1
1 
12.4±1.1a 10.6±1.3ab 9.2±1.1abc  7.0±0.37bc 6.3±0.8c 6.9±0.97bc  0.001 
ITGB6 45.5±4.1b 50.5±2.7b 53.9±2.9b  69.6±2.9a 77.2±7.9a 75.4±6.1a  <0.001 
ILK 51.7±2.4 47.3±1.5 45.9±2.3  58.2±2.2 54.8±7.1 57.0±4.6  0.168 
OCLN 81.7±10.0b 79.4±6.6b 92.2±11.8b  221.8±26.2a 185.1±29.3a 218.3±30.8a  <0.001 
CLDN12 15.9±2.1b 14.5±1.5b 12.7±1.0b  23.8±1.9a 18.1±1.8b 17.8±1.25b  0.001 
CLDN15 598.2±62.7c 540.1±63.3c 588.9±56.5c  1797±182a 1405.0±273
.2ab 
1319.4±139
.6b 
 <0.001 
TJP1 7.4±0.85c 6.2±0.45c 6.3±0.53c  14.0±1.2a 9.6±1.7b 9.7±0.89b  <0.001 
CDH1 372.7±30.8 381.2±46.6 309.1±39.6  305.6±28.2 288.9±39.6 274.6±31.9  0.231 
CDH17 995 ± 77.5ab 1090 ± 102.1a 970.0 ± 74.8ab  548.7±69.6c 722.3±118.
9bc 
587.1±95.9c  <0.001 
F11R 166.1 ± 19.1ab 172 ± 14.3ab 148.4 ± 13.1b  227.1±16.1a 210.3±22.3a 222.4±24.0a  0.021 
CXADR 64.1±7.7b 60.2±4.6b 69.1±9.7b  112.6±8.0a 101.8±8.7a 105.7±17.0a  0.001 
DSP 160.6±5.4bc 131.7±11.6c 121.7±7.0c  229.6±17.9a 212.2±24.2a
b 
211.2±24.3a
b 
 <0.001 
CX32.2 1608±163b 1862±193b 1537±146b  1276±212a 1290±238a 1350±98a  0.194 
CX32.7 0.96±0.19b 0.81±0.18b 0.89±0.13b  4.0±1.1a 3.4±0.64a 4.9±0.68a  <0.001 
GJB4 3.8±0.30b 3.3±0.29b 3.3±0.30b  5.5±0.5a 3.6±0.39b 3.9±0.17b  0.001 
MUC2 799±90.1 923±85 838±98  727±212 704±259 611±123  0.801 
MUC2-like 691.2±162.5 842.3±132.5 724.3±94.5  634.6±224 608.1±167 519.4±35.2  0.743 
MUC13 1214± 171 1217 ± 72 1073 ± 169  1200±225 713.9±43 1036±209  0.334 
I-MUC 7.4 ± 2.9b 5.6 ± 0.83b 6.3 ± 1.8b  836.8±161a 976.1±329a 637.1±134a  <0.001 
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Supplementary Table 3. Continued-II. 
 
Gene 
Anterior intestine  Posterior intestine  ANOVA 
CTRL D1 D2 CTRL D1 D2 P-value 
ALPI 1858±170a 2024±302a 845.2±172b  661.1±124.7b 600.9±146.4b 637.1±134.7b  <0.001 
FABP1 1698±307 1499±204 1478±205  796.6±492 654.2±365 701.1±272  0.107 
FABP2 2873± 597b 4523± 825b 9568 ± 914a  - - -  0.001 
FABP6 - - -  44725±14285 67844±19029 109784±24786  0.091 
CALR 692±126a 665.6±78a 512 ± 42ab  379.1±65.1b 330.9±50.8b 305.6±47.0b  0.002 
CANX 359.1±31.5ab 364± 27ab 289± 21ab  330±19a 280±39ab 255±22b  0.048 
GR 59±12 54±6.6 44.4±3.9  34.5±3.8 36.3±4.2 38.1±5.7  0.073 
GST3 704± 79a 745±60a 677±106a  280±45b 305±18b 280±39b  <0.001 
SOD1 248.0±32.0 300.9±16.9 302.4±18.5  179.6±37.4 214.5±43.3 211.6±38.0  0.062 
IL-1β 1.1±0.28a 0.54±0.07b 0.73±0.06b  1.8±0.52a 1.1±0.19ab 1.2±0.13ab  0.023 
IL-1R1 31.4±2.1 32.1±2.2 28.9±1.5  28.1±2.8 28.3±3.7 31.6±4.0  0.854 
IL-6 0.84±0.29a 0.19±0.04b 0.33±0.20b  1.28±0.48a 0.15±0.03b 0.33±0.15b  0.019 
IL-6R 17.3±3.8 13.3±1.8 12.9±2.0  17.2±1.9 14.8±1.7 16.5±2.7  0.656 
IL-7 23.4±2.7a 23.2±2.0a 17.8±3.4a  14.1±2.9ab 9.9±0.97b 9.3±0.79b  <0.001 
IL-15 12.2±1.9a 11.2±1.8ab 9.4±0.52ab  8.3±0.35b 7.1±1.1b 7.4±0.94b  0.037 
IL-8 11.8± 2.7a 8.8±2.4ab 4.5±0.56b  7.6±2.1ab 7.2±3.7ab 5.1±0.84ab  0.04 
IL-8RA 0.90±0.17b 0.64±0.07b 0.81±0.19b  2.2±0.34a 1.5±0.28ab 1.3±0.38b  0.004 
IL-10 4.3±1.0 3.4±0.73 4.1±0.80  7.2±0.74 5.5±1.9 6.4±1.4  0.251 
IL-10RA 15.6±2.9 10.3±1.0 9.8±0.96  12.2±1.4 10.1±1.3 14.8±3.2  0.200 
IL-34 21.6 ± 2.8 18.4 ± 2.4 17.8±1.5  24.1±0.52 19.5±2.9 19.9±2.8  0.443 
TNF-α 2.1±0.08 b 1.9±0.28b 1.7± 0.18b  3.0±0.38a 2.2±0.39ab 1.9±0.09b  0.030 
CSF1R1 7.2±1.4b 5.4±0.82b 6.0±1.9b  17.3±1.89a 12.7±1.7a 13.7±1.7a  <0.001 
CXC 57.7±10.3b 42.7±8.7b 57.0±13.9b  153.4±17.0a 129.0±16.0a 134.2±13.6a  <0.001 
CCL25 583.4±69.3 529.8±60.8 510.1±65.1  420.4±43.6 469.1±80.9 378.3±48.0  0.241 
CCR3 8.1±1.57ab 6.8±0.66b 7.1 ± 0.56b  12.1±1.7ab 10.6±2.2ab 11.7±1.1a  0.038 
CCR9 21.0±4.0b 18.2±2.1b 19.0 ± 2.5b  31.7±5.7ab 28.6±3.8ab 42.1±6.1a  0.003 
CCR11 64.9 ± 11.5 82.4±7.8 75.3±10.0  90.2±10.1 95.7±10.9 102.7±7.0  0.101 
CCL20 137.0±38.0 109.1±11.3 81.4±24.2  126.3±24.3 134.9±21.1 115.1±14.3  0.588 
CD48 55.6±4.3 49.1±2.4 47.9±3.8  46.4±2.3 42.4±3.26 49.0±5.0  0.253 
CD276 13.2±1.2 12.0±1.3 12.3±2.2  16.1±0.7 12.2±2.0 12.6±1.1  0.406 
TLR1 11.7±2.0ab 8.1±0.90b 8.3±0.67b  14.3±1.2a 10.3±1.1b 13.6±1.3a  0.006 
TLR2 5.2±0.82b 4.6±0.73b 4.8±0.88b  12.6±0.94a 9.9±1.1a 11.8±1.3a  <0.001 
TLR5 1.1±0.27b 0.61±0.11b 0.77 ± 0.14b  1.6±0.21a 0.93±0.17b 1.0±0.11b  0.004 
TLR9 0.69±0.03bc 0.78±0.12bc 0.5±0.05c  1.1±0.1a 0.65±0.09bc 1.0±0.16ab  0.001 
NOD1 19.0±1.2b 16.4±1.6b 16.7±1.2b  36.7±5.7a 27.4±3.5ab 26.2±2.2ab  <0.001 
MRC1 17.2± 2.8 13.5±1.1 13.3±1.6  18.0±1.7 13.9±1.8 17.7±1.4  0.207 
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Supplementary Table 3. Continued-III. 
 
Gene  
Anterior intestine  Posterior intestine  ANOVA 
CTRL D1 D2 CTRL D1 D2 P-value 
CD209 3.7±0.33 3.5±0.31 3.7±0.47  3.4±0.5 2.4±0.41 2.4±0.57  0.146 
CD302 127.9±10.81 133.4±15.1 123.7±10.6  143.5±4.1 126.5±13.4 138.3±11.9  0.821 
CLEC10A 0.77±0.11b 0.52±0.07b 0.61±0.10b  1.7±0.28a 0.94±0.16b 1.0±0.09b  <0.001 
LGALS1 123.6±11.2b 116.7±12.0b 141.1±33.9b  301.1±31.6a 206.6±26.7b 279.0±39.3a  <0.001 
LGALS8 49.8±4.1b 45.6±5.5b 43.0±3.6b  102.9±10.3a 87.8±15.0a 91.9±10.9a  <0.001 
CSL2 117.15±45.1 58.0±21.6 28.2±5.5  183.5±96.1 90.7±35.5 92.2±22.1  0.358 
FCL 62±28c 764±193b 217±129bc  381±68b 2334.7±963a 1271±600ab  0.033 
mtHsp10 94.1±10.5a 129.1±14.6a 105.5±15.2a  33.9±3.7b 38.2±8.1b 43.5±8.7b  <0.001 
mtHsp60 51.6±8.6a 58.0±9.2a 46.8± 11.3a  10.4±1.2b 13.0±4.2b 12.7±2.5b  <0.001 
mtHsp70 63.9±9.6ab 74.0±4.1a 71.5±14.5a  34.7±4.2b 34.9±4.2b 37.2±4.5b  0.001 
ECH 216.4±27.5c 427.6±43.0a 335.8±43.2b  111.4±21.5d 134.7±18d 143.0±13d  <0.001 
HADH 303.0±57.2b 456.6±43.9a 351.5±42.4ab  169.0±19.1c 219.7±18.0c 171.4±16.4c  <0.001 
CS 524.7±33.4a 630.0±56.6a 563.3±75.8a  277.4±44.9b 303.4±63.8b 314.9±57.2b  <0.001 
Tim44 8.4±0.72a 8.0±0.51a 6.0±0.65ab  6.6±0.85ab 4.8±0.6b 4.5±0.45b  0.001 
Tom22 28.6±2.0a 27.2±2.1ab 25.7±1.1ab  22.6±1.3b 21.8±1.5b 21.4±1.6b  0.018 
mtTFA 25.2±2.7 23.9±3.3 23.0±1.7  23.0±2.3 21.8±3.2 21.8±3.4  0.956 
NRF1 5.2±1.2 5.1±1.1 4.0±0.82  6.9±0.42 5.7±0.68 5.6±0.54  0.268 
PGC1α 43.6±4.2 43.8±5.0 40.5±7.0  40.8±4.0 33.2±5.6 35.6±6.2  0.696 
 
